Page last updated: 2024-11-02

perphenazine and Acute Confusional Senile Dementia

perphenazine has been researched along with Acute Confusional Senile Dementia in 7 studies

Perphenazine: An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.
perphenazine : A phenothiazine derivative in which the phenothiazine tricycle carries a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at N-10.

Research Excerpts

ExcerptRelevanceReference
" In this study of 45 elderly patients suffering from dementia and treated with perphenazine, 5 patients who were prospectively identified as poor P450 2D6 metabolizers had significantly greater side effects than the 40 extensive metabolizers."3.69Prospective cytochrome P450 phenotyping for neuroleptic treatment in dementia. ( Altieri, LP; Mulsant, BH; Perel, JM; Pollock, BG; Rosen, J; Sweet, RA, 1995)
"Alzheimer's disease is imposing a growing social and economic burden worldwide, and effective therapies are urgently required."1.91Perphenazine-Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid. ( Adamson, JSP; Ball, SR; Jiang, X; Kassiou, M; Knowles, TPJ; Kwan, AH; Lo, V; McKenzie, ADJ; Meisl, G; Rutledge, PJ; Sanz-Hernandez, M; Sullivan, MA; Sunde, M; Todd, MH; Werry, EL; Zimmermann, MR, 2023)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Necula, M1
Kayed, R1
Milton, S1
Glabe, CG1
Ball, SR1
Adamson, JSP1
Sullivan, MA1
Zimmermann, MR1
Lo, V1
Sanz-Hernandez, M1
Jiang, X1
Kwan, AH1
McKenzie, ADJ1
Werry, EL1
Knowles, TPJ1
Kassiou, M1
Meisl, G1
Todd, MH1
Rutledge, PJ1
Sunde, M1
Zhu, L1
Song, Y1
Cheng, PN1
Moore, JS1
Pollock, BG2
Mulsant, BH2
Sweet, RA2
Rosen, J2
Altieri, LP1
Perel, JM1
Lo, KH1
Yao, JK1
Henteleff, RA1
Mazumdar, S1
Levkovitz, Y1
Bloch, Y1
Kaplan, D1
Diskin, A1
Abramovitchi, I1
Baumann, P1
Eap, CB1
Zullino, DF1

Trials

2 trials available for perphenazine and Acute Confusional Senile Dementia

ArticleYear
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report.
    Biological psychiatry, 1997, Dec-01, Volume: 42, Issue:11

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavior; Dyskinesia, Drug-Induced

1997
Fluvoxamine for psychosis in Alzheimer's disease.
    The Journal of nervous and mental disease, 2001, Volume: 189, Issue:2

    Topics: Acute Disease; Aged; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Brief Psychiatric Rat

2001

Other Studies

5 other studies available for perphenazine and Acute Confusional Senile Dementia

ArticleYear
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
    The Journal of biological chemistry, 2007, Apr-06, Volume: 282, Issue:14

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Humans; Plaque, Amyloid; Protein Structu

2007
Perphenazine-Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid.
    ACS chemical neuroscience, 2023, 01-04, Volume: 14, Issue:1

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidogenic Proteins; Humans; Peptide Fragments

2023
Molecular Design for Dual Modulation Effect of Amyloid Protein Aggregation.
    Journal of the American Chemical Society, 2015, Jul-01, Volume: 137, Issue:25

    Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Circular Dichroism; Drug Des

2015
Prospective cytochrome P450 phenotyping for neuroleptic treatment in dementia.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:2

    Topics: Aged; Alzheimer Disease; Cytochrome P-450 Enzyme System; Dementia; Female; Humans; Male; Middle Aged

1995
Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.
    The Journal of nervous and mental disease, 2001, Volume: 189, Issue:11

    Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactio

2001